Skip to main content
Erschienen in:

27.04.2024 | ESCAP Communication

ESCAP statement on the care for children and adolescents with gender dysphoria: an urgent need for safeguarding clinical, scientific, and ethical standards

verfasst von: Maja Drobnič Radobuljac, Urh Grošelj, Riittakerttu Kaltiala, Robert Vermeiren, Sofie Crommen, Konstantinos Kotsis, Andrea Danese, Pieter J. Hoekstra, Jörg M. Fegert, the ESCAP Policy Division, the ESCAP Board

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 6/2024

Einloggen, um Zugang zu erhalten

Auszug

According to the DSM-5-TR [1] gender dysphoria refers to “…the distress that may accompany the incongruence between one’s experienced or expressed gender and one’s assigned gender”, requiring also the presence of “…clinically significant distress or impairment in social, school, or other important areas of functioning”; the DSM-5-TR lists gender dysphoria among mental disorders. In contrast, the latest ICD-11 [2] describes gender incongruence as a condition “…characterized by a marked and persistent incongruence between an individual’s experienced gender and the assigned sex”. In order to avoid the stigma connected to mental disordes and the “double stigmatisation” of this historically highly stigmatised population, the ICD-11 decided to remove the gender identity-related diagnoses from the section on mental disorders and include it in the section “Conditions Related to Sexual Health” [3]. As such, gender dysphoria is not a mental health disorder according to WHO definitions, but psychiatrists and other mental health professionals may be asked to be involved to address co-occurring mental health problems [4]. Even though not all people with gender incongruence experience distress or dysfunction, the condition can be accompanied by significant suffering and have a major psychosocial impact on the individual and the family, sometimes requiring medical and psychosocial interventions. Consequently, one of the major reasons for the decision to leave gender dysphoria diagnosis as a mental disorder in DSM-5-TR, was to enable funding for the provision of any medical and mental health treatments needed [3]. A proportion of people experiencing gender dysphoria (from here the term that calls for psychosocial and medical care will refer also to the more neutral term “gender incongruence” if not stated otherwise) pursue social, legal, and medical changes affirming their subjectively experienced gender. These may include presenting with the desired gender in their personal environments (e.g., family, friends, workplace, school, …) by using different names and pronouns—referred to as social transition. It may also include formal changes of their name and/or gender on documents—referred to as legal transition. Finally, medical transition can be achieved by prescription of cross-sex hormones (estrogens or testosterone, depending on subjects’ biological characteristics) and/or gender-reassigning surgical procedures including genital (gynecological, urological) and other (mastectomy, plastic surgery, and ear, nose, and throat surgery procedures) [5, 6]. …
Literatur
2.
Zurück zum Zitat World Health Organization (WHO) (2019/2021) International classification of diseases, eleventh revision (ICD-11). Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO licence (CC BY-ND 3.0 IGO). https://icd.who.int/browse11. Accessed 29 Feb 2024 World Health Organization (WHO) (2019/2021) International classification of diseases, eleventh revision (ICD-11). Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO licence (CC BY-ND 3.0 IGO). https://​icd.​who.​int/​browse11. Accessed 29 Feb 2024
3.
8.
Zurück zum Zitat Delemarre-van de Waal HA, Cohen-Kettenis PT (2006) Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects. Proceedings of the 4th Ferring Pharmaceuticals International Paediatric Endocrinology Symposium (Ferring Pharmaceuticals has supported the publication of these proceedings). Eur J Endocrinol 155(Supplement_1):S131–S137. https://doi.org/10.1530/eje.1.02231 Delemarre-van de Waal HA, Cohen-Kettenis PT (2006) Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects. Proceedings of the 4th Ferring Pharmaceuticals International Paediatric Endocrinology Symposium (Ferring Pharmaceuticals has supported the publication of these proceedings). Eur J Endocrinol 155(Supplement_1):S131–S137. https://​doi.​org/​10.​1530/​eje.​1.​02231
15.
18.
Zurück zum Zitat Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T’Sjoen GG (2017) Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 102(11):3869–3903. https://doi.org/10.1210/jc.2017-01658CrossRefPubMed Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T’Sjoen GG (2017) Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 102(11):3869–3903. https://​doi.​org/​10.​1210/​jc.​2017-01658CrossRefPubMed
20.
Zurück zum Zitat Telfer MM, Tollit MA, Pace CC, Pang KC (2020) Australian standards of care and treatment guidelines for trans and children and adolescents version 1.3. The Royal Children’s Hospital, Melbourne Telfer MM, Tollit MA, Pace CC, Pang KC (2020) Australian standards of care and treatment guidelines for trans and children and adolescents version 1.3. The Royal Children’s Hospital, Melbourne
21.
Zurück zum Zitat Di Ceglie D, Sturge C, Sutton A (1998) Guidance for the management of gender identity disorders in children and adolescents. Council Report CR63. Royal College of Psychiatrists, London Di Ceglie D, Sturge C, Sutton A (1998) Guidance for the management of gender identity disorders in children and adolescents. Council Report CR63. Royal College of Psychiatrists, London
36.
Zurück zum Zitat Laidlaw MK, Van Meter QL, Hruz PW, Van Mol A, Malone WJ (2018) Letter to the editor: “Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline.” J Clin Endocrinol Metab 104(3):686–687CrossRef Laidlaw MK, Van Meter QL, Hruz PW, Van Mol A, Malone WJ (2018) Letter to the editor: “Endocrine treatment of gender-dysphoric/gender-incongruent persons: an endocrine society clinical practice guideline.” J Clin Endocrinol Metab 104(3):686–687CrossRef
44.
52.
Zurück zum Zitat Zepf FD, König L, Kaiser A, Ligges C, Ligges M, Roessner V, Banaschewski T, Holtmann M (2024) Beyond NICE: Aktualisierte systematische Übersicht zur Evidenzlage der Pubertätsblockade und Hormongabe bei Minderjährigen mit Geschlechtsdysphorie. Z Kinder Jugendpsychiatr Psychother. https://doi.org/10.1024/1422-4917/a000972. (Epub ahead of print)CrossRefPubMed Zepf FD, König L, Kaiser A, Ligges C, Ligges M, Roessner V, Banaschewski T, Holtmann M (2024) Beyond NICE: Aktualisierte systematische Übersicht zur Evidenzlage der Pubertätsblockade und Hormongabe bei Minderjährigen mit Geschlechtsdysphorie. Z Kinder Jugendpsychiatr Psychother. https://​doi.​org/​10.​1024/​1422-4917/​a000972. (Epub ahead of print)CrossRefPubMed
Metadaten
Titel
ESCAP statement on the care for children and adolescents with gender dysphoria: an urgent need for safeguarding clinical, scientific, and ethical standards
verfasst von
Maja Drobnič Radobuljac
Urh Grošelj
Riittakerttu Kaltiala
Robert Vermeiren
Sofie Crommen
Konstantinos Kotsis
Andrea Danese
Pieter J. Hoekstra
Jörg M. Fegert
the ESCAP Policy Division
the ESCAP Board
Publikationsdatum
27.04.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Child & Adolescent Psychiatry / Ausgabe 6/2024
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-024-02440-8

Neu im Fachgebiet Psychiatrie

Digitale Therapie lindert Borderline-Persönlichkeitsstörung

Eine rein digitale Therapie ohne therapeutische Unterstützung kann die Symptomatik bei Borderline-Persönlichkeitsstörung bereits etwas lindern, auch scheint sie das Suizidrisiko zu mindern. Darauf deuten Ergebnisse einer großen kontrollierten Studie. Die Effekte sind aber eher gering.

Schadet Schichtarbeit dem Gehirn?

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Starke Menopausensymptome: ein Hinweis auf kognitive Veränderungen?

Stärkere Beschwerden in der Perimenopause sind mit einer reduzierten kognitiven Funktion in den mittleren und späteren Lebensjahren assoziiert. Auch das Verhalten kann sich ändern, wie eine Studie zeigt. Beides steht womöglich für erhöhte Demenzgefährdung.

Was tun, wenn pneumologische Medikamente Psyche und Blutbild verändern?

Arzneimittel für Patienten mit Mukoviszidose oder pulmonaler arterieller Hypertonie wirken offenbar nicht nur auf die Lunge. Was es in der Praxis zu beachten gilt, wurde beim Pneumologie-Kongress erläutert.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.